相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Utility of a Clinical Risk Factor Scoring Model in Predicting Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae on Hospital Admission
Steven W. Johnson et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection
Meltem Isikgoz Tasbakan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria
L. S. Briongos-Figuero et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum -lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
Wouter C. Rottier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Epidemiology and genetic characteristics of extended-spectrum -lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities
Marco Tinelli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010
Daryl J. Hoban et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
S. Meier et al.
INFECTION (2011)
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact
Jesus Oteo et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Prevalence and Risk Factors for Extended Spectrum Beta-Lactamase-Producing Uropathogens in Patients with Urinary Tract Infection
Dong Sup Lee et al.
KOREAN JOURNAL OF UROLOGY (2010)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Defining an extended-spectrum beta-lactamase
D. M. Livermore
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia:: a systematic review and meta-analysis
Mitchell J. Schwaber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline
Ralf Rene Reinert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections
Husnu Pullukcu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs:: A matched cohort study
Su Young Lee et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases
E Calbo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs
SE Cosgrove
CLINICAL INFECTIOUS DISEASES (2006)
Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004)
H Goossens et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
JDD Pitout et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Urologic Diseases in America project: Analytical methods and principal findings
MS Litwin et al.
JOURNAL OF UROLOGY (2005)
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients
J Rodríguez-Baño et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
The impact of antimicrobial resistance on health and economic outcomes
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection:: risk factors and clinical outcome
B Du et al.
INTENSIVE CARE MEDICINE (2002)
Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia
BN Kim et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific region
PL Winokur et al.
CLINICAL INFECTIOUS DISEASES (2001)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
Urinary tract pathogens in complicated infection and in elderly individuals
LE Nicolle
JOURNAL OF INFECTIOUS DISEASES (2001)
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2000)
Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients
MH Kollef
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
